Skip to Content Skip to Navigation


As a way to keep us all connected during this time, we thought it would be a great opportunity to offer you some updates directly from our NBCF-funded researchers through our Towards Zero webinar series.

NBCF-funded researcher Dr Tatyana Chtanova will talk about her groundbreaking research project on developing immunotherapies for triple negative breast cancer (TNBC). Dr Chtanova will address how her new approach to the treatment of TNBC tumours in experimental models will hopefully result in new treatment options in the future.

You will learn:

  • Why treatment for TNBC is an area that needs to be addressed
  • How Dr Chtanova’s project will improve treatment for TNBC
  • How Dr Chtanova’s project will use a clinically approved approach that will ensure for a faster translation of the outcomes into clinical practice to improve the life of those with TNBC


Key Details:

  • Date: 30th June 2020
  • Time: 11:00 AM (AEST)
  • Length: 30 Minutes
  • Price: Free, RSVP Required

Other episodes: